Results 131 to 140 of about 80,748 (261)
Opinion: Reproducibility failures are essential to scientific inquiry. [PDF]
Redish AD +3 more
europepmc +1 more source
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Research Hypothesis: A Brief History, Central Role in Scientific Inquiry, and Characteristics. [PDF]
Ghasemi A +3 more
europepmc +1 more source
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
Dr. Himmatrao Bawaskar: Transforming Rural Healthcare Through Scientific Inquiry and Advocacy. [PDF]
Kawalkar U +3 more
europepmc +1 more source
The Great Opportunity: Cultivating Scientific Inquiry in Medical Residency. [PDF]
Vyas JM +7 more
europepmc +1 more source
Circulating tumor cells (CTCs) and plasma cell‐free DNA (cfDNA) were analyzed to detect ESR1 mutations and methylation in patients with advanced breast cancer. CTC‐derived DNA showed higher sensitivity for mutation detection and revealed complementary genetic and epigenetic alterations, highlighting the added value of CTC analysis for understanding ...
Dimitra Stergiopoulou +12 more
wiley +1 more source
The Telescoping Phenomenon: Origins in Gender Bias and Implications for Contemporary Scientific Inquiry. [PDF]
Marks KR, Clark CD.
europepmc +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
Poster Development and Presentation to Improve Scientific Inquiry and Broaden Effective Scientific Communication Skills. [PDF]
Rauschenbach I, Keddis R, Davis D.
europepmc +1 more source

